Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394524 · ClinicalTrials.gov registry record · NA
Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT00394524 is a NA study that has completed, run by Emory University. The registered enrollment target is 160 participants.
The verdict
NCT00394524, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The study is a multicenter, prospective, open-label randomized study to compare the safety and efficacy of continuous insulin infusion (CII) via a computer-guided(Glucommander) and a standard paper form protocol among the patients hospitalized in a medical intensive care unit (ICU). .
Interventions
- DEVICE Glucommander
- OTHER Standard insulin infusion algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00394524
The ClinicalTrials.gov registry entry for NCT00394524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Glucommander is the first listed.
NCT00394524 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00394524 about?
NCT00394524 is a clinical study titled "Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU". The study is a multicenter, prospective, open-label randomized study to compare the safety and efficacy of continuous insulin infusion (CII) via a computer-guided(Glucommander) and a standard paper form protocol among the patients hospitalized in a medical intensive care unit (ICU). .
What is the current status of trial NCT00394524?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2006-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00394524?
The interventions under investigation include: Glucommander (DEVICE), Standard insulin infusion algorithm (OTHER).
Who is sponsoring clinical trial NCT00394524?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.